Twitter Roundup

Posted by Dan Vorhaus on September 3, 2010

With so many developments at the intersection of genomics and the law, there are often a variety of interesting stories that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here is a recap of what I was Tweeting recently @genomicslawyer:

Stem Cell Madness: http://bit.ly/a49pDy Great analysis by Hank Greely on the hESC ruling
RT @westr: “Imagine having your complete genome… Would your doctor embrace this scenario?” via @MishaAngrist http://bit.ly/dcxlk0
Round-up of how medical schools are familiarizing students with DTC genomics, including a novel approach from @westr: http://bit.ly/a386Bg
Congrats! RT @MishaAngrist: My blog, GenomeBoy, is part of the new PLoS Blogosphere. http://bit.ly/dmpg83
Poll question for you: does UM State Fair DNA collection proj survive to 2011 in current form, or go the way of Berkeley?
Kids swap DNA for fairground rides: http://bit.ly/diHdMQ (@NatureNews by @ewencallaway)
Surprise, surprise: PacBio denies Helicos’ patent infringement allegations: http://bit.ly/dnzO3N
BioServe ‘Networks’ with Several Academic Centers to Launch Large Biosample Repository: http://bit.ly/aRqzNp Like emphasis on transparency
What an actual FDA warning letter to a DTC (non-genetic) company looks like: http://bit.ly/cJMOdd
More on the impact of NIH stimulus funds drying up next month (from @BloombergNews v@mary_carmichael): http://bit.ly/bUr6Nu
Genetic Tests Get Mixed Results for Blood Thinners (from @scotthensley): http://n.pr/9AS9Ri
Helicos Files Patent Infringement Suit against PacBio: http://bit.ly/cfwMX7 by @gw_dailyscan H/T @lindaavey
RT @FierceBiotech: Research scientists brace for layoffs as stimulus cash dries up. http://bit.ly/aaGlUw
GLR Post: The Business Effects of Regulatory Uncertainty in Genetic Testing: http://bit.ly/aG7yHA
Personalized Med mtg hosted by @burrillreport & @DukeIGSP has great lineup, including @PersonalizedMed & @mcguireamy: http://bit.ly/95TfKj
My podcast on @burrillreport on the GPMA, personalized medicine & why DTC is not dead: http://bit.ly/a4H5Ab
RT @wilbanks: Gerry Barnett (@umbut) on patents, tech transfer, and the commons. http://bit.ly/doXHmZ
Paul Allen sues Silicon Valley: http://bit.ly/cN5WmW v @WSJ Highlights need for patent system reform across the board
Halt to NIH hESC research follows halt to funding. DOJ expected to appeal today. http://bit.ly/b1YI9b (via @ScienceInsider)
RT @mary_carmichael, @saletan ESC therapy gets chance to prove itself — or blow its political power. http://bit.ly/cJ20Lm
RT @matthewherper: My take on $SNY’s “bear hug” of Genzyme from yesterday: http://ow.ly/2wCQB
Keith Robison handicaps the race to the ‘arbimagical’ $1K genome: http://bit.ly/deoHkq (HT @gw_dailyscan)
RT @PHGFoundation: Current DTC genetic testing market smaller than expected http://bit.ly/bRuBCb
RT @bmahersciwriter: Strong words from the NIH director on stem cell court ruling http://bit.ly/cmTpgs via @edwardwinstead @mishaangrist
Is the IPO Market Warming up to Genomics? http://bit.ly/czYNDC Good background, analysis from T. Fong of @gw_dailyscan
RT @DukeIGSP: RT @C_G_S: Class Cancelled: Media Coverage of UC Berkeley’s Retreat on Gene Tests http://bit.ly/cJnI7u
FDA extends comment period for LDT oversight to 9/15: http://bit.ly/axXvPX The waiting continues.
Agree: restrictive & hard to define MT @eurogene: big hurdle in ESHG DTC guidelines is req of clinical utility http://bit.ly/9hJVeG
Further support for open consent: MT @dgmacarthur: Genealogy dbs may impair privacy for research subjects: http://tinyurl.com/2wpg48f
The Seven Deadly Sins of Science Journalism: http://bit.ly/clwxuE Science 2.0 via @mary_carmichael
RT @ewencallaway: Euro Soc for Hum Gen puts out DTC-genetics guidelines. http://bit.ly/bxvKoD
RT @JohnCFierce: NIH holding on to ~$75M in ESC funding. For now. Bitter pill for researchers to swallow. BLMBG: http://bit.ly/a7oICB
New GLR Post: The Cost of Regulating LDTs: http://bit.ly/9YTWQ5
“The Medical Revolution” from @slate http://bit.ly/cstPw4 Not just another “it’s been 10 years; genomics has failed” article.
RT @jasonbobe: New breed of start-ups innovating low-cost lab equip: nice profile of 3 PCR machines/founders: http://bit.ly/garage_pcr
Not all of the $10BN has been spent yet (see: ESC) RT @GenomeWeb_News: Biden Hails Recovery Act’s Genomics Goal: http://bit.ly/dcVzOx
Here is the stem cell injunction order if you are interested: http://bit.ly/cfACuC It’s mostly a plain language rebuff to NIH / Obama
DOJ to appeal stem cell federal funding injunction: http://bit.ly/baBlAt
RT @matthewherper: George Church (@geochurch) on the stem cell injunction: http://bit.ly/c4Mryc
On need for pheno-geno data: “It’s kind of a pain in the ass to have that kind of info. & not have medical history.” http://bit.ly/cua8XC
More on Hugh Rienhoff from @bmahersciwriter RT @NatureNews: For a trailblazer, an answer in genetics? http://ff.im/-pEKHX
RT @NatureMedicine: “Stunned” NIH director puts embryonic stem cell work on hold http://ff.im/-pEJlq
Re: $ILMN Q&A, Kahn says genomic data is “fundamental to the individual” but requires professional with training “to read the tea leaves”
Illuminating Q&A w/ CIO Scott Kahn re: $ILMN’s plans for mobile genomics apps: http://bit.ly/aaMUUG Strong focus on clinical, not consumer.
Not waiting for FDA to dev LDT policy, Arrayit pursues PMA for ovarian cancer dx: http://bit.ly/dmUvLp
RT @markgfh: My analysis of the US court decision blocking embryonic stem cell research: http://bit.ly/dnJ0YY (£)
District Court challenges Obama’s EO allowing use of federal funds for embryonic stem cell research: http://bit.ly/bhZNJi
RT @ewencallaway @bmahersciwriter: Hugh Rienhoff May have a Candidate Gene in His Daughter’s DNA http://bit.ly/9FzOZf
New GLR Post: The Genomics & Personalized Medicine Act Returns to Congress: http://bit.ly/9jeRoI